Benefits of once-daily therapies in the treatment of hypertension

References

• ChobanianAVBakrisGLBlackHRSeventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension20034261206125214656957
   PubMed Web of Science ®Google Scholar
• FlackJMSicaDABakrisGManagement of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statementHypertension201056578080020921433
   PubMed Web of Science ®Google Scholar
• ZannadFPractical relevance of the 24-hour trough: peak ratio of antihypertensive drugsJ Hypertens Suppl1995132S1091128576780
   PubMedGoogle Scholar
• MeredithPAElliottHLFDA guidelines on trough: peak ratios in the evaluation of antihypertensive agentsJ Cardiovasc Pharmacol199423Suppl 5S26307609502
   PubMedGoogle Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
   PubMed Web of Science ®Google Scholar
• ElliottHLTrough: peak ratio and twenty-four-hour blood pressure controlJ Hypertens Suppl1994125S29337965283
   PubMedGoogle Scholar
• Mounier-VehierCBernaudCCarreALequeucheBHottonJMCharpentierJCCompliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-releaseAm J Hypertens1998114 Pt 14784869607387
   PubMed Web of Science ®Google Scholar
• MeredithPANew FDA guidelines on the treatment of hypertension: comparison of different therapeutic classes according to trough/peak blood pressure responsesArch Mal Coeur Vaiss19948711142314297771888
   PubMedGoogle Scholar
• ChiVXChauNPAntihypertensive effect of drugs: statistical distribution of the trough-to-peak ratioBiometrics19965212862908934597
   PubMed Web of Science ®Google Scholar
• SoucekMRihacekIFranaPA comparison of the trough-to-peak ratio of cardio-selective beta-blockers in patients with newly diagnosed hypertensionBlood Press Monit200611633734217106318
   PubMed Web of Science ®Google Scholar
• MeredithPAACE inhibition and AT1 receptor blockers: efficacy and duration in hypertensionHeart200084Suppl 1i39i41 discussion i5010956321
   PubMedGoogle Scholar
• ZanchettiATrough: peak ratio of the blood pressure response to dihydropyridine calcium antagonistsJ Hypertens Suppl1994128S971067707165
   PubMedGoogle Scholar
• PatelPVWongJLAroraRThe morning blood pressure surge: therapeutic implicationsJ Clin Hypertens (Greenwich)200810214014518259124
   PubMed Web of Science ®Google Scholar
• AmiciACicconettiPSagrafoliCExaggerated morning blood pressure surge and cardiovascular events. A 5-year longitudinal study in normotensive and well-controlled hypertensive elderlyArch Gerontol Geriatr2009492e105e10919070375
   PubMedGoogle Scholar
• GossePNeutelJMSchumacherHLacourciereYWilliamsBDavidaiGThe effect of telmisartan and ramipril on early morning blood pressure surge: a pooled analysis of two randomized clinical trialsBlood Press Monit200712314114717496463
   PubMed Web of Science ®Google Scholar
• LacourciereYNeutelJMDavidaiGKovalSA multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoringAm J Hypertens200619110411216461201
   PubMed Web of Science ®Google Scholar
• WilliamsBGossePLoweLHarperRThe prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I)J Hypertens200624119320016331118
   PubMed Web of Science ®Google Scholar
• HermidaRCAyalaDEMojonAAlonsoIFernandezJRReduction of morning blood pressure surge after treatment with nifedipine GITS at bedtime, but not upon awakening, in essential hypertensionBlood Press Monit200914415215919543080
   PubMed Web of Science ®Google Scholar
• ManciaGParatiGCastiglioniPDaily life blood pressure changes are steeper in hypertensive than in normotensive subjectsHypertension200342327728212885790
   PubMed Web of Science ®Google Scholar
• BonaduceDCanonicoVPetrettaMTwenty-four-hour blood pressure monitoring during treatment with extended-release felodipine versus slow-release nifedipine in elderly patients with mild to moderate hypertension: a randomized, double-blind, cross-over studyEur J Clin Pharmacol1997532951009403278
   PubMed Web of Science ®Google Scholar
• ZannadFMatzingerALarcheJTrough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonistsAm J Hypertens1996976336438806975
   PubMed Web of Science ®Google Scholar
• WingLMTrough: peak ratio of the blood pressure response to betablockersJ Hypertens Suppl1994128S85907707162
   PubMedGoogle Scholar
• SeverPSDahlofBPoulterNRRationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigatorsJ Hypertens20011961139114711403364
   PubMed Web of Science ®Google Scholar
• RothwellPMHowardSCDolanEEffects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of strokeLancet Neurol20109546948020227347
   PubMed Web of Science ®Google Scholar
• AalbersJReduced blood pressure variability in ASCOT-BPLA trial favours use of amlodipine/perindopril combination to reduce stroke riskCardiovasc J Afr201021211520532438
   PubMed Web of Science ®Google Scholar
• GoyalDChongAYWatsonRLPrasadNWatsonRDAssessment of single versus twice daily dosing of ramipril by ambulatory blood pressure monitoring in patients similar to those included in the HOPE studyJ Hum Hypertens200721752553017460714
   PubMed Web of Science ®Google Scholar
• RoutledgeFMcFetridge-DurdleJNondipping blood pressure patterns among individuals with essential hypertension: a review of the literatureEur J Cardiovasc Nurs20076192616843730
   PubMedGoogle Scholar
• WhiteWBImportance of blood pressure control over a 24-hour periodJ Manag Care Pharm2007138 Suppl BS3439
   PubMed Web of Science ®Google Scholar
• De la SierraARedonJBanegasJRPrevalence and factors associated with circadian blood pressure patterns in hypertensive patientsHypertension200953346647219171788
   PubMed Web of Science ®Google Scholar
• KarioKShimadaKDifferential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressureAm J Hypertens19971032612689056682
   PubMed Web of Science ®Google Scholar
• WhiteWBMehrotraDVBlackHRFakouhiTDEffects of controlled- onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). COER-Verapamil Study GroupAm J Cardiol19978044694749285660
   PubMed Web of Science ®Google Scholar
• HermidaRCCalvoCAyalaDEAdministration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjectsHypertension200342328329012874091
   PubMed Web of Science ®Google Scholar
• SvenssonPde FaireUSleightPYusufSOstergrenJComparative effects of ramipril on ambulatory and office blood pressures: a HOPE substudyHypertension2001386E283211751742
   PubMed Web of Science ®Google Scholar
• YusufSSleightPPogueJBoschJDaviesRDagenaisGEffects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study InvestigatorsN Engl J Med2000342314515310639539
   PubMed Web of Science ®Google Scholar
• HermidaRCAyalaDEMojonAFernandezJRInfluence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC studyChronobiol Int20102781629165120854139
   PubMed Web of Science ®Google Scholar
• CocaACalvoCSobrinoJOnce-daily fixed-combination irbesartan 300 mg/hydrochlorothiazide 25 mg and circadian blood pressure profile in patients with essential hypertensionClin Ther2003251128492864
   PubMed Web of Science ®Google Scholar
• SeverPCandesartan cilexetil: a new, long-acting, effective angiotensin II type 1 receptor blockerJ Hum Hypertens199711Suppl 2S91959331018
   PubMedGoogle Scholar
• McInnesGTAngiotensin II antagonism in clinical practice: experience with valsartanJ Cardiovasc Pharmacol199933Suppl 1S2932 discussion S41–4310028951
   PubMedGoogle Scholar
• AndersonOKNeldamSThe antihypertensive effect and tolerability of candesartan cilexetil, a new generation angiotensin II antagonist, in comparison with losartanBlood Press19987153599551878
   PubMedGoogle Scholar
• SmithDHMatzekKMKempthorne-RawsonJDose response and safety of telmisartan in patients with mild to moderate hypertensionPharmacol20004012 Pt 113801390
   Web of Science ®Google Scholar
• Accupril^® (quinapril hydrochloride tablets) [prescribing information]New York, NYParke-Davis, Division of Pfizer Inc2009 Available from: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=12730Accessed November 30, 2009
   Google Scholar
• Capoten^® (captopril tablets) [prescribing information]Spring Valley, NYPar Pharmaceutical Companies, Inc2005 Available from: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=4492Accessed November 30, 2009
   Google Scholar
• Aceon^® (perindopril erbumine tablets) [prescribing information]Marietta, GASolvay Pharmaceuticals, Inc2005 Available from: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=9343Accessed November 30, 2009
   Google Scholar
• Lotensin^® (benazepril hydrochloride tablets) [prescribing information]East Hanover, NJNovartis Pharmaceuticals Corp2009 Available from: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=12230Accessed November 30, 2009
   Google Scholar
• Plendil^® (felodipine tablets) extended-release [prescribing information]Wilmington, DEAstraZeneca, LP2007 Available from: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=11574Accessed November 30, 2009
   Google Scholar
• DynaCirc CR^® (isradipine tablets), extended release [prescribing information]Liberty Corner, NJReliant Pharmaceuticals, Inc2007 Available from: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=4147Accessed November 30, 2009
   Google Scholar
• VerdecchiaPCalvoCMockelVKeelingLSatlinASafety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertensionBlood Press200716638139118058456
   PubMed Web of Science ®Google Scholar
• MallionJMAsmarRBoutelantSGuezDTwenty-four hour antihypertensive efficacy of indapamide, 1.5-mg sustained release: results of two randomized double-blind controlled studiesJ Cardiovasc Pharmacol19983246736789781939
   PubMed Web of Science ®Google Scholar
• GuezDMallionJMDegauteJPTreatment of hypertension with indapamide 1.5 mg sustained-release form: synthesis of resultsArch Mal Coeur Vaiss199689Spec No 417258952810
   PubMedGoogle Scholar
• FlorasJSJonesJVHassanMOSleightPAmbulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranololBr Med J (Clin Res Ed)1982285635213871392
   PubMedGoogle Scholar
• NeutelJMSchnaperHCheungDGGraettingerWFWeberMAAntihypertensive effects of beta-blockers administered once daily: 24-hour measurementsAm Heart J199012011661712360502
   PubMed Web of Science ®Google Scholar
• StoschitzkyKStoschitzkyGBrusseeHBonelliCDobnigHComparing beta-blocking effects of bisoprolol, carvedilol and nebivololCardiology2006106419920616679760
   PubMed Web of Science ®Google Scholar
• WeberMABakrisGLTarkaEAIyengarMFleckRSicaDAEfficacy of a once-daily formulation of carvedilol for the treatment of hypertensionJ Clin Hypertens (Greenwich)200681284084917170609
   PubMedGoogle Scholar
• KuroedovACosentinoFLuscherTFPharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivololCardiovasc Drug Rev200422315516815492765
   PubMedGoogle Scholar
• CocaASobrinoJSolerJTrough-to-peak ratio, smoothness index, and circadian blood pressure profile after treatment with once-daily fixed combination of losartan 100 and hydrochlorothiazide 25 in essential hypertensionJ Cardiovasc Pharmacol200239682483312021576
   PubMed Web of Science ®Google Scholar
• KuschnirEBenderskyMReskJEffects of the combination of low-dose nifedipine GITS 20 mg and losartan 50 mg in patients with mild to moderate hypertensionJ Cardiovasc Pharmacol200443230030514716221
   PubMed Web of Science ®Google Scholar
• ManciaGOmboniSParatiGTwenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT)J Hypertens200220354555311875324
   PubMed Web of Science ®Google Scholar
• PalatiniPMalaccoEDiSSTrough: peak ratio and smoothness index in the evaluation of 24-h blood pressure control in hypertension: a comparative study between valsartan/hydrochlorothiazide combination and amlodipineEur J Clin Pharmacol2002571176577011868797
   PubMed Web of Science ®Google Scholar
• MaciejewskiSMohiuddinSMPackardKARandomized, double-blind, crossover comparison of amlodipine and valsartan in African-Americans with hypertension using 24-hour ambulatory blood pressure monitoringPharmacotherapy200626788989516803420
   PubMed Web of Science ®Google Scholar
• RadauceanuABoivinJMBernaudCFayRZannadFDifferential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocolFundam Clin Pharmacol200418448349115312156
   PubMed Web of Science ®Google Scholar
• ZannadFBernaudCMFayRDouble-blind, randomized, multicentre comparison of the effects of amlodipine and perindopril on 24 h therapeutic coverage and beyond in patients with mild to moderate hypertensionJ Hypertens199917113714610100105
   PubMed Web of Science ®Google Scholar
• LacourciereYAsmarRA comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration studyAm J Hypertens19991212 Pt 1–21181118710619580
   PubMed Web of Science ®Google Scholar
• OhkuboTHozawaAYamaguchiJPrognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama studyJ Hypertens200220112183218912409956
   PubMed Web of Science ®Google Scholar
• WhiteWBAmbulatory blood pressure monitoring: dippers compared with non-dippersBlood Press Monit20005Suppl 1S172310904238
   PubMedGoogle Scholar
• DolanEStantonAThijsLSuperiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome studyHypertension200546115616115939805
   PubMed Web of Science ®Google Scholar
• PalatiniPRacioppaARauleGZaninottoMPenzoMPessinaACEffect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinaprilClin Pharmacol Ther1992523783831330398
   PubMed Web of Science ®Google Scholar
• HermidaRCAyalaDEFernándezJRCalvoCComparison of the efficacy of morning versus evening administration of telmisartan in essential hypertensionHypertension200750471572217635851
   PubMed Web of Science ®Google Scholar
• PortaluppiFVergnaniLManfrediniRdegli UbertiECFersiniCTime-dependent effect of isradipine on the nocturnal hypertension in chronic renal failureAm J Hypertens1995877197267546498
   PubMed Web of Science ®Google Scholar
• KarioKShimadaKPickeringTGClinical implication of morning blood pressure surge in hypertensionJ Cardiovasc Pharmacol200342Suppl 1S879114871036
   PubMedGoogle Scholar
• StaessenJAThijsLFagardRPredicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial InvestigatorsJAMA1999282653954610450715
   PubMed Web of Science ®Google Scholar
• OhkuboTMetokiHImaiYPrognostic significance of morning surge in blood pressure: which definition, which outcome?Blood Press Monit200813316116218496293
   PubMed Web of Science ®Google Scholar
• ParatiGFainiAValentiniMBlood pressure variability: its measurement and significance in hypertensionCurr Hypertens Rep20068319920417147917
   PubMed Web of Science ®Google Scholar
• TatascioreARendaGZimarinoMAwake systolic blood pressure variability correlates with target-organ damage in hypertensive subjectsHypertension200750232533217562971
   PubMed Web of Science ®Google Scholar
• ParatiGPomidossiGAlbiniFMalaspinaDManciaGRelationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertensionJ Hypertens19875193983584967
   PubMed Web of Science ®Google Scholar
• FrattolaAParatiGCuspidiCAlbiniFManciaGPrognostic value of 24-hour blood pressure variabilityJ Hypertens19931110113311378258679
   PubMed Web of Science ®Google Scholar
• CramerJABenedictAMuszbekNKeskinaslanAKhanZMThe significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a reviewInt J Clin Pract2008621768717983433
   PubMed Web of Science ®Google Scholar
• SchroederKFaheyTEbrahimSHow can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trialsArch Intern Med2004164772273215078641
   PubMedGoogle Scholar
• BramleyTJGerbinoPPNightengaleBSFrech-TamasFRelationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizationsJ Manag Care Pharm200612323924516623608
   PubMed Web of Science ®Google Scholar
• KarveSClevesMAHelmMHudsonTJWestDSMartinBCGood and poor adherence: optimal cut-point for adherence measures using administrative claims dataCurr Med Res Opin20092592303231019635045
   PubMed Web of Science ®Google Scholar
• HansenRAKimMMSongLTuWWuJMurrayMDComparison of methods to assess medication adherence and classify nonadherenceAnn Pharmacother200943341342219261962
   PubMed Web of Science ®Google Scholar
• IskedjianMEinarsonTRMacKeiganLDRelationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysisClin Ther200224230231611911560
   PubMed Web of Science ®Google Scholar
• ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther20012381296131011558866
   PubMed Web of Science ®Google Scholar
• AndrejakMGenesNVaurLPonceletPClersonPCarreAElectronic pill-boxes in the evaluation of antihypertensive treatment compliance: comparison of once daily versus twice daily regimenAm J Hypertens200013218419010701819
   PubMed Web of Science ®Google Scholar
• LeenenFHWilsonTWBolliPPatterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoringCan J Cardiol199713109149209374947
   PubMed Web of Science ®Google Scholar
• PerreaultSDragomirAWhiteMLalondeLBlaisLBerardABetter adherence to antihypertensive agents and risk reduction of chronic heart failureJ Intern Med2009266220721819623691
   PubMed Web of Science ®Google Scholar
• KettaniFZDragomirACoteRImpact of a better adherence to antihypertensive agents on cerebrovascular disease for primary preventionStroke200940121322019038916
   PubMed Web of Science ®Google Scholar
• SafarMEJankowskiPCentral blood pressure and hypertension: role in cardiovascular risk assessmentClin Sci200911627328219138169
   PubMed Web of Science ®Google Scholar
• RomanMJDevereuxRBKizerJRCentral pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Hearth StudyHypertension20075019720317485598
   PubMed Web of Science ®Google Scholar
• RomanMJOkinPMKizerJRLeeETHowardBVDevereuxRBRelations of central and brachial blood pressure to left ventricular hypertrophy and geometry: the Strong Heart StudyJ Hypertens201028238438820051906
   PubMed Web of Science ®Google Scholar
• BoutouyriePBussyCLacolleyPGirerdXLalouxBLaurentSAssociation between local pulse pressure, mean blood pressure, and large-artery remodelingCirculation1999100131387139310500038
   PubMed Web of Science ®Google Scholar
• MorganTLauriJBertramDAndersonAEffect of different antihypertensive drug classes on central aortic pressureAm J Hypertens20041711812314751652
   PubMed Web of Science ®Google Scholar
• HirataKVlachopoulosCAdjiAO’RourkeMFBenefits from angiotensin- converting enzyme inhibitor “beyond blood pressure lowering”: beyond blood pressure or beyond the breachial arteryJ Hypertens20052355155615716696
   PubMed Web of Science ®Google Scholar
• DhakamZMcEnieryCMYasminCockcroftJRBrownMJWilkinsonIBAtenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocityAm J Hypertens20061921421916448896
   PubMed Web of Science ®Google Scholar
• DhakamZYasminMcEnieryCMBurtonTBrownMJWilkinsonIBA comparison of atenolol and nebivolol in isolated systolic hypertensionJ Hypertens200826235135618192850
   PubMed Web of Science ®Google Scholar